Cargando…

Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study

Mostrar otras versiones (1)

COVID19 in patients affected by lymphoma represents an important challenge because of the higher mortality rate. Anti‐SARS‐CoV‐2 monoclonal antibodies (anti‐S MoAbs) appear promising in this setting. We report a monocentric retrospective study including 176 patients affected by lymphoma which develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assanto, Giovanni Manfredi, Di Rocco, Alice, Malfona, Francesco, Capriata, Marcello, Del Giudice, Ilaria, Petrucci, Luigi, Girardi, Paola, D’Elia, Gianna Maria, Martelli, Maurizio, Gentile, Giuseppe, Micozzi, Alessandra, Pulsoni, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877821/ https://www.ncbi.nlm.nih.gov/pubmed/36521843 http://dx.doi.org/10.1002/hon.3113

Ejemplares similares

Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2022)

Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment
por: Di Rocco, Alice, et al.
Publicado: (2022)

Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

High Basal Maximal Standardized Uptake Value (SUV(max)) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2021)

S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

P1232: NON-INVASIVE MINIMAL RESIDUAL DISEASE ANALYSIS BY IMMUNOGLOBULIN GENE REARRANGEMENTS ON CIRCULATING TUMOR DNA PREDICTS THE OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Soscia, Roberta, et al.
Publicado: (2023)

Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?
por: Pulsoni, A., et al.
Publicado: (2023)

Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy
por: Perrone, Salvatore, et al.
Publicado: (2016)

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
por: Maccioni, Francesca, et al.
Publicado: (2023)

The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
por: Assanto, Giovanni M., et al.
Publicado: (2021)

Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic
por: Micozzi, Alessandra, et al.
Publicado: (2021)

Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study
por: Micozzi, Alessandra, et al.
Publicado: (2023)

High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy
por: Visentini, Marcella, et al.
Publicado: (2023)

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination
por: Masucci, Chiara, et al.
Publicado: (2023)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

The monoclonality of human B-cell lymphomas
Publicado: (1977)

Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
por: Gotti, Manuel, et al.
Publicado: (2023)

Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report
por: Di Palma, Martina, et al.
Publicado: (2022)

COVID‐19 pneumonia and pulmonary microembolism in a patient with B‐thalassemia major
por: Marziali, Marco, et al.
Publicado: (2020)

Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
por: Perrone, Salvatore, et al.
Publicado: (2023)

Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies
por: Ciccarelli, Giovanni, et al.
Publicado: (2018)

Monoclonal immunoglobulin light chains in urine of patients with lymphoma.
por: Pierson, J., et al.
Publicado: (1980)

Unusual human lymphoma phenotype defined by monoclonal antibody
Publicado: (1980)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort
por: Scalzulli, Emilia, et al.
Publicado: (2022)

Hodgkin’s lymphoma: post- autologous transplantation consolidation therapy
por: Merli, Francesco, et al.
Publicado: (2020)

Lymphadenopathies before and during the Pandemic COVID-19: Increasing Incidence of Metastases from Solid Tumors
por: Trasarti, Stefania, et al.
Publicado: (2022)

Nematicons: spatial optical solitons in nematic liquid crystals
por: Assanto, Gaetano
Publicado: (2013)

Response to Interferon-Free Direct Antivirals (DAAS) Treatment in Hcv-Related Subcutaneous Marginal Zone B-Cell Lymphoma with Lipoma-Like Presentation: Report of Two Cases
por: De Luca, Maria Lucia, et al.
Publicado: (2019)

Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2018)

Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
por: Motta, Giulia, et al.
Publicado: (2010)

90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years
por: Casadei, Beatrice, et al.
Publicado: (2016)

A Case of Recurrent Proliferative Glomerulonephritis with Monoclonal IgG Deposits after Kidney Transplant Treated with Plasmapheresis
por: Ranghino, Andrea, et al.
Publicado: (2012)

Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia
por: Guarini, Anna, et al.
Publicado: (2023)

Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
por: Micozzi, Alessandra, et al.
Publicado: (2017)

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2020)

Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion
por: Gridelli, Cesare, et al.
Publicado: (2023)

Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component
por: Cox, M. Christina, et al.
Publicado: (2014)

Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study
por: Facondo, Giuseppe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vke0aa3c9n090t1509c3almth7